News Center

Company Information

Industry Trends

A Brilliant Recap | Jiangsu Lekai Concludes with a Resounding Success at COA 2025!

A Brilliant Recap | Jiangsu Lekai Concludes with a Resounding Success at COA 2025!

From November 12 to 16, 2025, the 24th Orthopaedic Academic Conference of the Chinese Medical Association and the 17th COA Academic Congress were grandly held at the Tianjin National Convention and Exhibition Center. Focusing on the theme "Intelligent Orthopaedics · Exploring Future Frontiers," the conference attracted tens of thousands of orthopaedic professionals from across the country to participate in this grand event.

16

2025

/

11

Jiangsu Lekai "Collagen" obtained ISO 13485:2016 standard management system certification!

Jiangsu Lekai "Collagen" obtained ISO 13485:2016 standard management system certification!

Jiangsu Lekai Biotechnology Co., LTD. (hereinafter referred to as "Jiangsu Lekai") "collagen raw material" quality management system in accordance with: ISO 13485:2016 standard, obtained the management system certification certificate, certificate No. : C718165.

21

2025

/

01

Review | Jiangsu Lekai in 2024 COA

Review | Jiangsu Lekai in 2024 COA

Jiangsu Lekai presented a large number of innovative orthopedic and regenerative products.

10

2024

/

12

Chen Heping, member of the leading Party group and deputy director of Jiangsu Drug Administration, investigated Jiangsu Lekai Biotechnology Co., LTD

Chen Heping, member of the leading Party group and deputy director of Jiangsu Drug Administration, investigated Jiangsu Lekai Biotechnology Co., LTD

From October 17 to 18, Chen Heping, member of the Leading Party group and deputy director of the Drug Administration of Jiangsu Province, visited Zhangjiagang to investigate the development of medical device industry.

21

2024

/

10

Jiangsu Lekai completed the master document registration of "type Ⅰ collagen" medical device!

Jiangsu Lekai completed the master document registration of "type Ⅰ collagen" medical device!

Recently, Jiangsu Lekai Biotechnology Co., LTD. (hereinafter referred to as "Jiangsu Lekai") has successfully passed the State Food and Drug Administration medical device master document registration, master document registration number: M2024279-000.

04

2024

/

09

< 12 >